Term
Goals for treatment of Rheumatoid arthritis |
|
Definition
- Rlieve symptoms
- Delay joint damage
|
|
|
Term
Drugs used for symptom relief of rheumatoid arthritis |
|
Definition
- NSAIDs: These are taken chronically. Make sure patient does not end up with a GI bleed. Use Cox-2 selective in patients prone to bleeding. These do NOT modify the disease progression
- Corticosteroids: Reduce pain and swelling and also SLOW disease progression. But to slow progression, need really high doses, so start these super high, then taper off to reduce side-effects.
- Disease modifying Anti-Rheumatic Drugs (DMARDs): These drugs are poorly tolerated except for methotrexate. These are going to ALL alter the rate at which the joints are lost to RA.
|
|
|
Term
|
Definition
MOA:
- Dihydrofolate reductase inhibitor and blocks the synthesis of purines needed for DNA/RNA synthesis.
Use:
- Very potent immunosupressive activity so useful in cancer chemotherapy
- Treatment of immune disease
- Low dose = treatment of RA
|
|
|
Term
Methotrexate
Side effects |
|
Definition
Low dose: (so when treating RA)
High dose:
- Severe WBC depression
- Cirrhosis of the liver
- Pneumonia-like symptoms (pneumonitis) (might not go away when you remove the drug)
|
|
|
Term
|
Definition
MOA:
- Monocolonal Ab that binds to TNF-alpha
- Chimeric Ab of human/mouse
Use:
- Used in combination with methotrexate
|
|
|
Term
Infliximab
Adverse effect |
|
Definition
- Upper respiratory infections is the most common effect
- Concern of immunologic reaction b/c this is a chimeric compound
|
|
|
Term
|
Definition
- Recombinant protein that have two soluble portions of TNF-alpha receptor molecule and the Fc portion of human IgG
- Binds to two molecules of TNF-alpha
|
|
|
Term
|
Definition
MOA:
- This is like infliximab but uses entirely human monoclonal Ab
|
|
|
Term
|
Definition
- Approved for Rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis
|
|
|
Term
|
Definition
- Used for RA and Crohn's disease
- Reserved for patients that fail on other DMRAs
|
|
|
Term
Leflunomide
MOA
Use
Side-effects |
|
Definition
MOA:
- Inhibition of tyrosine kinase activity
- Inhibits pyrimidine biosynthesis in de novo
Use:
- Alternative to methotrexate
Side effects:
- Elevated liver enzymes
- Other toxicities b/c of suppression of fast-tunover cells
|
|
|
Term
|
Definition
Use:
- Treating moderate-severe RA when patients have inadequate response to TNF-alpha inhibitors
- These are costimulation modulators
MOA:
- Renders T-cells inactive by not allowing them to become activated → thereby decreasing T-cell-mediated inflammation + joint damage from RA
- Abatacept binds to CD80 and CD86 and blocks T-cell activation
|
|
|
Term
|
Definition
- T cells are activated by first binding to an antigen-presenting cell (APC) → then having CD28 interact with CD80 or CD86 on the APC → causes activation
|
|
|
Term
When do you use abatcept?
Contraindications |
|
Definition
- Patients w/moderate-severe RA that do not benefit from methotrexate or TNF-alpha inhibitors are candidates
- Can reverse some of the sings of joint damage (disease modification)
- Can be given with methotrexate but do NOT use in combination with TNF-alpha inhibitors b/c increases incidence of infection
- Contraindications: TNF-alpha treatment or someone w/COPD b/c can worsen COPD
|
|
|
Term
|
Definition
MOA:
- Reduces B-lymphocytes by targeting CD20-containing B-lymphocytes
Use:
- Given w/methotrexate
- Used for moderate-severe RA that does not respond to TNF-alpha drugs
|
|
|
Term
|
Definition
- Flu-like symptoms
- Can also cause breathing problems
- Cardiac rhythm problems
- Cardiogenic shock (this is the most severe reaction that can occur and happens after the first-dose)
|
|
|
Term
Sulfasalazine
MOA
Side-effects
Use |
|
Definition
MOA:
- Mmeber of sulfa drugs class
- Poorly absorbed in GI tract → bacteria change it to sulfapyridine (sulfa-antibiotic) and 5-amino-salicylate (anti-inflammatory)
Side effects:
- Hypersensitivity reaction due to sulfa allergy
|
|
|
Term
Sulfasalazine
Use
Side-effects |
|
Definition
- Inflammatory bowel diseases
- Ulcerative colitis
- Crohn's disease
- 2nd line for autoimmune diseases (RA, ankylosing spondylitis, seronegative spondyloarthropathy)
- Good for alternative to methotrexate for patients with liver disease
Causes GI problems |
|
|
Term
Hydroxychloroquine
General info
Toxicity |
|
Definition
General:
- Anti-malaterial drugs (hydroxhloroquine and chloroquine) are rapidly absorbed and safe/well-tolerated
- Effective for treatment of RA especially if mild
Toxicity:
- Ocular is the most dangerous (corneal deposits, extraocular muscle weakness, loss of accommodation, and reinopathy → irreversible loss of vision)
|
|
|
Term
|
Definition
- Gold sodium thiomalate
- Aurothioglucose
- Auranofin
|
|
|
Term
|
Definition
Use:
- Gold salts supress but do NOT cure RA
- Have a minimal effect on inflammation in other circumstances
- Cause gradual reduction of signs/symptoms of RA induced inflammation
- Used in early, active arthritis, esp. for diseases that progresses despitre adequate NSAIDs
MOA:
- Inhibit the maturation and fucntion of mononuclear phagocytes and T-cells → suppressing immune response
|
|
|
Term
|
Definition
- Most common are the ones associated with lesions of the skin and mucousal membranes (usually of the mouth)
- Can have simple erythema → severe exfoliative dermatits
- Other effects are kidney damage + blood dyscrasias
|
|
|
Term
D-penicillamine
Used for?
Side-effects? |
|
Definition
- Analog of cysteine
- Slows bone destruction in RA via unknown MOA
- Only used if other treatments have failed
Side effects
- Dermatological problems
- Nephritis
- Aplastic anemia
|
|
|
Term
Examples of IL-1 receptor antagonists |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
- IL-1 found in synovial tissue of joints
- IL-1 stimulates its own increased production (positive feedback) → causes increased PG-E2, NO, and metalloproteases → which causes increased joint degradation
- Macrophages also release IL-1 but ALSO release a compound that binds to the IL-1 receptor that serves as an antagonist called interleukin-1 reeptor antagonist (IL-1ra)
|
|
|
Term
Anakinra and IL-1ra
What are they?
What are they used for?
Contraindications? |
|
Definition
What are they/use:
- Anakinra is a recombinant form of the human IL-1ra
- Efficacy as a DMARD is good
- Well tolerated
Contraindications:
- Do not give with TNF-alpha inhibitor → severe infection
|
|
|
Term
IL-6 receptor Ab drug examples |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
IL-6 receptor Ab
MOA
Benefit |
|
Definition
Tocilizumab + Actemra
MOA:
- Bind to and inactivate IL-6 receptors
- IL-6 is secreted by macroaphages and T-cells → stimulates immune reponse (esp. in area of injury)
- IL-6 also stimulates osteoclast formation → enhanced bone reabsorption
Dosing benefit:
- One benefit is once monthly administration
|
|
|
Term
|
Definition
Adverse events:
- Upper respiratory tract infection
- Elevated BP + headache
- Elevated liver enzymes
- Elevated LDL
- Decreased neutrophil + platelet counts
- Serious AE = infection, GI perfration, and HS reaction (anaphylaxis)
- Increased risk for cancer
Because of all the side-effects, only use with patients that have failed on TNF-alpha therapy |
|
|
Term
Other immunosuppressant drug examples |
|
Definition
Cyclosporine
Azathioprine |
|
|
Term
|
Definition
General:
- Complex cyclic peptide isolated from fungus
Use:
- Immunosuppressive agent in organ transplants
- Reserved for patients that fail to respond to other therapies
MOA:
- Inhibits T-lymphocytes very selectively
|
|
|
Term
Cyclosporine
Adverse effects |
|
Definition
|
|
Term
Azathioprine
MOA
Toxicity |
|
Definition
MOA:
- Purine anti-metabolite
- Interferes w/purine synthesis
- Also causes DNA damage by formation of "false nucleotide" substrates for DNA synthesis
Toxicity:
- Bone marrow suppression
- Hepatotoxicity
|
|
|
Term
|
Definition
B/c of side effects, use is limited to:
- Treatment of transplant rejection
- Cancer
- Severe refractory RA
- Systemic lupus erythematosus
|
|
|
Term
|
Definition
MOA:
- Nitrogen mustard
- Alkylating agent that alkylates DNA and interferes w/synthesis and function → leads to B-cell and T-cell suppression b/c they require DNA formation to activate and also inhibits all rapidly proliferating tissues
Use:
- Anti-cancer agent
- Severe autoimmune diseases especially systemic complications such as vasculitis
|
|
|
Term
|
Definition
MOA:
- Causes local depletion of substance-P (a neuropeptide that is involved in transmission of pain impulses)
- It is applied topically to relieve pain associated with rheumatoid arthritis and osteoarthritis
|
|
|
Term
Primary way to help prevent/decrease gout? |
|
Definition
- Exercise
- Weight control
- Healthy diet
- Smoking cessation
- Alcohol cessation
- Hydration
|
|
|
Term
|
Definition
- Organ meats (liver)
- High-fructose corn syrup
- Ecessive alcohol use
|
|
|
Term
Foods to limit during gout |
|
Definition
- Large protions/concentrations of meat + seafood
|
|
|
Term
Encouraged foods for gout |
|
Definition
- Low-fat/non-fat dairy
- Low-fat/non-fat vegetables
|
|
|
Term
Agents for the treatment of gout |
|
Definition
- NSAIDs
- Colchicine
- Allopurinol
- Febuxostat
- Uricosuric agents (probenecid + sulfinpyrazone)
|
|
|
Term
DOC for acute attacks of gout? |
|
Definition
- Indomethacin (also used for PG-E2 inhibitor and helps to close the ductus arteriosus)
|
|
|
Term
|
Definition
Why do we use them:
- Besides inhibiting PG-synthesis, NSAIDs inhibit phagocytosis of urate cyrstals but you MUST USE HIGH DOSES!!! Low doses of NSAIDs and aspirin MUST NOT BE USED because this will inhibit renal secretion
- Higher doses inhibit both secretion + reabsorption which results in greatly enhanced elimiation in the urine
|
|
|
Term
Colchicine
Use in gout?
MOA |
|
Definition
Why do we use it:
- This is almost diagnostic of gout pain b/c it ONLY treats pain associated with gout
MOA:
- Binds tubulin + mitotic spindles + other micro-tubular structures → cuases arrest of cell division + cell mobility and decreases the secretion of granules (need microtubules for this)
|
|
|
Term
|
Definition
- Diarrhea, nausea, vomiting, and abdominal pain (causes this b/c cells are unable to devide in the gut and causes malabsorption and alter GI lining)
- Long term use leads to myopathy, agranulocytosis, aplastic anemia, and alopecia
|
|
|
Term
What are the drugs that are preferred and are considered the standard of care for treating gout? |
|
Definition
|
|
Term
|
Definition
MOA:
- Purine analog that competitively inhibits the last two steps in urice acid biosytnehsis that is catalyzed by xanthine oxidase
Use:
- Treatment of primary hyperuricemia of gout
- Hyperuriciemia secondary to other causes such as malignancy or renal disease
|
|
|
Term
|
Definition
- Most common SE is hypersensitivity
- Upon initial administration, may cause an acute attack of gout → so to alleviate this issue, start with lower doses of allopurinol and also give colchicine. Once allopurinol has caused a decreased concentration of uric acid in the blood, colchincine can be withdrawn
|
|
|
Term
|
Definition
MOA:
- Xanthine oxidase inhibitor
- Decreases urate levels more than allopurinol but NO benefit in terms of reduced number or severity of attacks of gout have been found
Use:
- "Reserved" for patients that cannot take allopurionol
- But this is starting to show to be more effective and so clinicans are starting to lean toward using this
|
|
|
Term
Uricosuric
Drug examples
Basic MOA |
|
Definition
Drug examples:
- Probenecid
- Sulfinpyrazone
- Aspirin (NSAIDs)
Basic MOA:
- "Pardoxical effect"
- Low dose = increase serum uric acid b/c decrease excretion
- High dose = decrease serum uric acid b/c increase excretion by blocking both secretion and reabsorption, but reabsorption inhibition has more of an impact
|
|
|
Term
|
Definition
Use:
- Low dose use was originally to decrease secretion of antibiotics when antibiotic supply was low
MOA:
- Blocks tubular secretion (at low dose) and reabsorption (at high dose) of organic acids (such as uric acid)
- The uricouric action of probenecid is BLUNTED by salicylates and to make things worse, the excretion of these drugs is decreased in the presence of probenecid, so DO NOT give them together
|
|
|
Term
Probenecid
Side effects
Contraindications |
|
Definition
- Well tolerated in most
- Low incidence of GI irritation
- Use with caution in patients with a history of peptic ulcers
- Hypersensitivity reactions
Contraindications
- Patients prone to urate stone formation
- Decrease renal function
|
|
|
Term
Sulfinpyrazone
Use
MOA
Drug interactions/side effects |
|
Definition
Uricosuric action is additive to that of probenecid
MOA:
- Inhibitor of renal acid reabsorption
- Also inhibits renal tubular secretion
Side effects/drug interactions:
- Hypoglycemia by inhibiting metabolism of oral hypoglycemic agents
- Warfarin metabolism is also impaired
- GI-irritation
|
|
|
Term
What should you tell a patient on uricosuric agents? |
|
Definition
Drinks lots of water because these are going to increase the chances of formation urate stones |
|
|
Term
Treatment for osteoporosis |
|
Definition
Estrogen (maybe)
Bisphosphonates
|
|
|
Term
Biphophate ("dronate" drugs)
MOA
Side effects |
|
Definition
MOA:
- Bind to bone → taken up by osteoclasts → cause apoptosis of osteoclasts and also prevent resorption by directly binding to the calcium/phosphate mineralizations
Side effects:
- Esophagitis: Less frequent administration reduces this. Decrease incidence by taking on empty stomach and standing up after taking it.
- Osteonecrosis of the jaw: Dose related
- GI irritation: Poorly absorbed
|
|
|